Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Nef

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 15, 2023
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertensionLaila Widmann, Stanislav Keranov, Leili Jafari, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisStephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, et al.
Biomarkers in Medicine|July 22, 2021
Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertensionStanislav Keranov, Oliver Dörr, Leili Jafari, et al.
JACC. Cardiovascular Interventions|February 16, 2016
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA RegistriesCorrado Tamburino, Piera Capranzano, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2016
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registryToru Naganuma, Antonio Colombo, Maciej Lesiak, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 26, 2017
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU RegistryPiera Capranzano, Davide Capodanno, Salvatore Brugaletta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2017
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended RegistryBoris Schnorbus, Jens Wiebe, Davide Capodanno, et al.
Biomarkers in Medicine|February 15, 2023
GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertensionStanislav Keranov, Laila Widmann, Leili Jafari, et al.
Journal of the American Heart Association|April 26, 2022
Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary InterventionHimanshu Rai, Fiona Harzer, Tatsuhiko Otsuka, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2015
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registryTommaso Gori, Jens Wiebe, Davide Capodanno, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 15, 2023
Fibroblast growth factor 23 as a biomarker of right ventricular dysfunction in pulmonary hypertensionLaila Widmann, Stanislav Keranov, Leili Jafari, et al.
JACC. Cardiovascular Interventions|September 23, 2017
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold ThrombosisStephen G Ellis, Giuseppe Steffenino, Dean J Kereiakes, et al.
Biomarkers in Medicine|July 22, 2021
Osteopontin and galectin-3 as biomarkers of maladaptive right ventricular remodeling in pulmonary hypertensionStanislav Keranov, Oliver Dörr, Leili Jafari, et al.
JACC. Cardiovascular Interventions|February 16, 2016
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA RegistriesCorrado Tamburino, Piera Capranzano, Tommaso Gori, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 15, 2016
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registryToru Naganuma, Antonio Colombo, Maciej Lesiak, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 26, 2017
Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU RegistryPiera Capranzano, Davide Capodanno, Salvatore Brugaletta, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 22, 2017
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended RegistryBoris Schnorbus, Jens Wiebe, Davide Capodanno, et al.
Biomarkers in Medicine|February 15, 2023
GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertensionStanislav Keranov, Laila Widmann, Leili Jafari, et al.
Journal of the American Heart Association|April 26, 2022
Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary InterventionHimanshu Rai, Fiona Harzer, Tatsuhiko Otsuka, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2015
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registryTommaso Gori, Jens Wiebe, Davide Capodanno, et al.
Pageof 23